EP (European Parliament) considers organ and tissue trafficking:
This article was originally published in Clinica
Executive Summary
The European Parliamentary Committee on the Environment, Public Health and Consumer Protection is scheduled to adopt on July 9 a draft opinion on the prevention and control of trafficking in human organs and tissues. Some of these issues have already been addressed by the Parliament in its amendment on the proposed directive on the quality and safety of tissues and cells. German MEP Peter Liese suggests that the Council should wait until the directive on tissues and cells has been adopted before adopting a framework decision on trafficking in human organs and tissues under the "third pillar" of the EU structure, which deals with co-operation in justice and home affairs.
You may also be interested in...
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip